Wordt geladen...
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancer
Immune checkpoint inhibitors (ICI) have been validated as an effective new treatment strategy in several tumoral types including lung cancer. This remarkable shift in the therapeutic paradigm is in large part due to the duration of responses and long-term survival seen with ICI. However, despite thi...
Bewaard in:
| Gepubliceerd in: | Transl Lung Cancer Res |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8264336/ https://ncbi.nlm.nih.gov/pubmed/34295689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-839 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|